期刊文献+

CD1_D基因与B7-1基因共转染胰腺癌细胞及其抗癌作用的实验研究 被引量:1

Study of cotransfection of B7-1 gene and CD1_D gene in pancreatic carcinoma cell and its anti-tumor responses in mice
下载PDF
导出
摘要 目的观察共转染小鼠B7-1和CD1D基因对小鼠胰腺癌细胞的免疫应答。方法将表达B7-1和CD1D基因的逆转录病毒载体导入包装细胞系,然后转染入胰腺癌细胞。用PCR和Western方法鉴定细胞表达;用B7-1和CD1D阳性的细胞在体内诱导抗肿瘤免疫反应。结果B7-1和CD1D阳性的细胞在同基因小鼠体内能诱导抗肿瘤免疫反应并抑制肿瘤生长。结论B7-1基因和CD1D基因共转染肿瘤细胞,能抑制肿瘤生长,可能为肿瘤的基因治疗开辟一条新途径。 Objective To study the cotransfection roB7-1 and mCD 1D gene into pancreatic cancer cells of rats and to observe its anti-tmor responses. Methods Recombinant retroviral vectors expressing mB7-1 and mCD1D gene were packaged into GP2 - 293 cell lines and transfected. The expressions of mB7-1 and mCD1D were detected with PCR and Western blot. The positive cells of mB7-1 and mCD1D were used to induce the anti-tumor immunity in vitro. Results Anti-tumor immunity was induced after B7-1 and CD1D positive cells were coinoculated in syngeneic mice. Furthermore, the growth of tumor was inhibited. Conclusions Cotransfection of B7-1 and CD1D could induce anti-tumor effect. This study provide a foundation for the application of B7-1 and CD1D gene therapy in tumor.
出处 《中国普通外科杂志》 CAS CSCD 2007年第5期442-445,共4页 China Journal of General Surgery
关键词 基因 CD1D 基因 B7-1 转染 胰腺癌细胞 Genes, CD1D Genes, B7-1 Transfection Pancreatic Carcinoma Cell
  • 相关文献

参考文献9

  • 1吕丽红,张波,曾庆东,邵军,尹金岺.5-LOXmRNA和VEGFmRNA在胰腺癌中的表达及其临床意义[J].中国普通外科杂志,2005,14(11):813-816. 被引量:3
  • 2Linsley PS,Brady W,Grosmaire L,et al.Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.[J] Exp Med,1991,173(3):721-730.
  • 3Porcelli SA,Modlin RL.The CD1 system:antigen-presenting molecules for T cell recognitionof lipids and glycolipids[J].Ann Rev Immunol,1999,17(3):297-329.
  • 4Barnaba V,Watts C,De Boer M,et al.Professional presentation of antigen by activated human T cells[J].Eur J Immunol,1994,24(1):71-75.
  • 5Carreno BM,Collins M.The B7 family of ligands and its receptors:new pathways for costimulation and inhibition of immune responses[J].Ann Rev Immunol,2002,20(1):29-53.
  • 6Yashiro Y,Tai XG,Toyo-oka K,et al.A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other co-stimulatory molecules[J].Eur J Immunol,1998,28(3):926-935.
  • 7Gruss HJ,Pinto A,Duyster J,et al.Hodgkin's disease:a tumor with disturbed immunological pathways[J].Immunol Today,1997,18(4):156-163.
  • 8Gerlini G,Hefti HP,Kleinhans M,et al.CD1D is expressed on dermal dendritic cells and monocyte-derived dendritic cells[J].J Invest Dermatol,2001,117(3):576-582.
  • 9Ausubel FM,Brent R,Kingdom RE,et al.Current Protocols in Molecular Biology[M].NewYork:John Wiley & Sons,Inc,2003,177.

二级参考文献6

共引文献2

同被引文献19

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1):11-30.
  • 2Canna K, McArdle PA, McMillan DC, et al. The relationship between tumour T-lymphocyte infihralion, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer[J]. Br J Cancer, 2005, 92(4):651-654.
  • 3Tsuta K, Ishii G, Kim E, et al. Primary lung adenocareinoma with massive lymphocyte infiltration[J]. Am J Chn Pathol, 2005, 123(4):547-552.
  • 4Schillaci R, Salatino M, Cassataro J, et al. Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway[J]. J Immunol, 2006, 176(6):3426-3437.
  • 5Reim D, Loos M, Vogl F, et al. Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution[J]. J Clin Oncol, 2013, 31 (2):263-271.
  • 6Kohlberger PD, Breitenecker F, Kaider A, et al. Modified true- color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison[J]. Anticancer Res, 1999, 19(3B):2189-2193.
  • 7Liu S, Lachapetle J, Leung S, et al. CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer[J]. Breast Cancer Res, 2012, 14(2):R48.
  • 8Cao X. Regulatory T cells and immune tolerance to tumors[J]. Immunol Res, 2010, 46(1-3):79-93.
  • 9Lee S, Margolin K. Tumor-infiltrating lymphocytes in melanoma[J]. Curr Oncol Rep, 2012, 14(5):468-474.
  • 10Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer[J]. N Engl J Med, 2003, 348(3):203-213.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部